Heartseed(ハートシード)株式会社はiPS細胞による心臓の再生医療を実現します。慶應義塾大学医学部循環器内科福田恵一教授の技術を用いて心不全の治療を目指す革新的な大学発ベンチャーです。
Location: Japan, Tokyo
Employees: 11-50
Total raised: $77.33M
Founded date: 2015
Investors 2
Date | Name | Website |
- | Medical In... | medicalinc... |
- | Angel Brid... | angelbridg... |
Funding Rounds 3
Date | Series | Amount | Investors |
25.05.2023 | Series D | $14.33M | UTokyo Inn... |
11.06.2021 | Series C | $37M | - |
22.11.2019 | Series B | $26M | - |
Mentions in press and media 10
Date | Title | Description | Source |
02.11.2023 | Using iPS Cells from I Peace, Heartseed Succeeds in Stable P... | PALO ALTO, Calif., Nov. 2, 2023 /PRNewswire/ -- Leading GMP cell CDMO I Peace, Inc. (https://www.ipe... | en.prnasia... |
25.05.2023 | Heartseed Raises 2 Billion JPY in Series D Funding | Heartseed, a Tokyo, Japan-based biotechnology company developing iPSC-derived cardiomyocytes for hea... | finsmes.co... |
29.03.2022 | Heartseed Inc. Heartseed decides to adopt “Innovation TOKYO ... | Heartseed Inc. Heartseed decides to adopt “Innovation TOKYO Project that opens up the future” It was... | re-how.net... |
11.06.2021 | Heartseed Raises $37M in Series C Funding | Heartseed, a Tokyo, Japan-based biotechnology company developing iPSC-derived cardiomyocytes for hea... | finsmes.co... |
11.06.2021 | Heartseed Raises $37 Million in Series C Funding to Accelera... | Heartseed, a Tokyo-based biotechnology company developing iPSC-derived cardiomyocytes for heart fail... | marketscre... |
26.11.2019 | Daily funding roundup - November 25th, 2019 | Osome landed $3M; Rad AI raised $4M; Heartseed secured $26M; v2food picks up $35M Osome: Osome is a ... | vator.tv/n... |
22.11.2019 | Heartseed Secures $26M in Series B Funding | Heartseed, a Tokyo, Japan-based biotechnology company developing iPSC-derived cardiomyocytes for the... | finsmes.co... |
22.11.2019 | Top tech startup news for today, Friday, November 22, 2019 –... | Good morning! Below are some of the top tech startup news for today, Friday, November 22, 2019. Tes... | techstartu... |
22.11.2019 | Tokyo tech startup Heartseed secures $26M Series B to accele... | Cardiovascular disease is the number one killer worldwide. Enter Heartseed, a developing PSC-derived... | techstartu... |
- | Heartseed | - | fastfounde... |